IPP Bureau
Lupin Atlantis Holdings to acquire accretive established products in Europe and Canada from Sanofi
By IPP Bureau - December 23, 2023
The brands Aarne in Germany and Nalcrom in Canada and the Netherlands are being acquired
USFDA grants priority review for Patritumab Deruxtecan in US for certain patients with EGFR-mutated non-small cell lung cancer
By IPP Bureau - December 23, 2023
If approved, patritumab deruxtecan would be a first-in-class HER3 directed DXd antibody drug conjugate for these patients
UPM Biomedicals enters into distribution agreement with Brinter for GrowInk bioinks
By IPP Bureau - December 23, 2023
The agreement grants Brinter the distribution rights of GrowInk bioinks in many countries
Natco Pharma and Breckenridge dismissed from antitrust lawsuit
By IPP Bureau - December 22, 2023
Ami Organics inks MoU with a global manufacturer of electrolytes
By IPP Bureau - December 22, 2023
Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business
Strides Pharma Science extends guarantee to Trinity Pharma Proprietary’s borrowing
By IPP Bureau - December 22, 2023
Trinity has availed credit facility from Investec for Business for their working capital requirements of Rs. 31.5 crore
Lupin launches liquid fibre Softovac Liquifibre
By IPP Bureau - December 22, 2023
Softovac Liquifibre expands the Softovac product portfolio and provides a choice for consumers who prefer time-tested Ayurvedic ingredients
JB Pharma buys opthalmology brands from Novartis for Rs 964 Cr
By IPP Bureau - December 22, 2023
JB Chemicals will pay Rs 125 crore to Novartis to license the same drug portfolio for the Indian market
Abbott India MD Vivek Kamath resigns
By IPP Bureau - December 22, 2023
His resignation would be effective from March 18, 2024
Digital transformation key to managing rising organisational healthcare costs in India
By IPP Bureau - December 22, 2023
Employer-sponsored health insurance costs in India are expected to rise by 11% in 2024
Piramal Pharma Solutions commissions ADC manufacturing expansion in Scotland
By IPP Bureau - December 21, 2023
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
AGC invests US$ 348 million to expand its biopharmaceutical CDMO capability
By IPP Bureau - December 21, 2023
Development services for gene and cell therapies is planned to begin first in 2025
Norms for fixing prices of medicines
By IPP Bureau - December 20, 2023
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
NHA organizes a multi-stakeholder meet for ABDM microsites
By IPP Bureau - December 20, 2023
ABDM Microsites Mobile Application for field officers and ABDM Microsites Dashboard launched for effective on-ground implementation and monitoring
FDA grants priority review to Merck’s new biologics license application for V116
By IPP Bureau - December 20, 2023
V116 is an investigational, 21-valent pneumococcal conjugate vaccine specifically designed to protect adults
